Ambicare Health, who's lead product is the Ambulight PDT, the world's first light emitting sticking plaster for the treatment of skin cancer, is pleased to announce positive new independent research on the use of the Ambulight PDT to treat Gorlin Syndrome. At the Gorlin Syndrome Group Annual Patient Conference held on 23 October, Dr Ernest Allan, a leading Oncologist from one of the UK's centres ...